HILTON BOSTON WOBURN | BOSTON, MA

SEPTEMBER 25-27 2018

Carl de Moor
Carl de Moor
Senior Director & Head of Global RWE Strategy, Analytics & Biostatistics
Biogen
Dr. Christoph Koenen, Cardiovascular Marketed Products Development Lead at Bristol-Myers Squibb
Christoph Koenen
Head of Cardiovascular Development, Therapeutic Area Head
Bristol-Myers Squibb
Christy Houle
Christy Houle
Director, HEOR
Lundbeck
David Anstatt
David Anstatt
Executive Director -
Observational Research
& Data Sciences
Bristol-Myers Squibb
David Thompson_Syneos Health 2
David Thompson
Senior Vice President, RWE Advisory
Syneos Health
EMily Brouwer
Emily Brouwer
Director, Epidemiology & Head of Data Science in Outcomes Research & Epidemiology
Shire Pharmaceuticals
9715 - Advisory Board RWE IMPACCT- Frank Zhang
Frank Zhang
VP Market Access -
Global Strategy & US,
Alnylam
Pharmaceuticals
Kristin Kostka_ConvergeHELATH by Deloitte
Kristin Kostka
Data Science Lead
ConvergeHEALTH by Deloitte
Louis Fiore
Louis Fiore
Executive Director - Massachusetts Veterans Epidemiology Research & Information Center
VA Boston Healthcare System
Marc Berger_Shyft Analytics
Marc Berger
Chair, Real World Evidence
Product Advisory Board
Shyft Analytics
Marcie Strauss
Marcie Strauss
Associate Director, HEOR
Intercept Pharmaceuticals
9715 - Speaker - Margaret McDonald
Margaret McDonald
Senior Director, Real World
Data & Analytics,
Pfizer
download
Mary Jo Lamberti
Associate Director of Sponsored Research & Associate Research Professor,
Tufts CSDD
9715 - Speaker - Melvin Olson
Melvin “Skip” Olson
Global Head Real World Data
Strategy & Innovation
Novartis
Michael Benecky
Michael Benecky 
Senior Director, Global Regulatory Affairs
GlaxoSmithKline
Nathalie Horowicz-Mehler_IQVIA
Nathalie Horowicz-Mehler
Senior Principal, RWAS Enterprise Solutions (GBU)
IQVIA
9715 - Speaker - Sam Whipple
Samuel Whipple
Data Scientist, Personalized Healthcare
Genentech
9715 - Speaker - Slava Akmaev
Slava Akmaev
Senior Vice President & Chief
Analytics Officer
Berg
Tyler Ludlow
Tyler Ludlow
(former-Senior Decision
Scientist, Eli Lilly & Company),
President
Decision Science Advisory